loader
Please Wait
Applying Filters...

AbbVie Header AbbVie Header

X

List of Crenolanib Besylate NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DISHMAN CARBOGEN AMCIS LIMITED (1)

filter

01 CRENOLANIB BESYLATE (1)

filter

01 India (1)

URL Supplier Web Content
CRENOLANIB BESYLATE
POWDER (1kg/kg)
BULK INGREDIENT
61876-0722
2014-12-15
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 670220-93-6 / Crenolanib Besylate API manufacturers, exporters & distributors?

Crenolanib Besylate manufacturers, exporters & distributors 1

27

PharmaCompass offers a list of Crenolanib Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Crenolanib Besylate manufacturer or Crenolanib Besylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Crenolanib Besylate manufacturer or Crenolanib Besylate supplier.

PharmaCompass also assists you with knowing the Crenolanib Besylate API Price utilized in the formulation of products. Crenolanib Besylate API Price is not always fixed or binding as the Crenolanib Besylate Price is obtained through a variety of data sources. The Crenolanib Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Crenolanib Besylate

Synonyms

670220-93-6, Crenolanib besilate, Crenolanib besylate [usan], Aro-002-26, Cp-868,596-26, Mc4b01024k

Cas Number

670220-93-6

Unique Ingredient Identifier (UNII)

MC4B01024K

About Crenolanib Besylate

Crenolanib Besylate is the besylate salt form of crenolanib, an orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with potential antineoplastic activity. Upon oral administration, crenolanib binds to and inhibits both wild-type and mutated forms of PDGFR and Flt3, which may result in the inhibition of PDGFR- and Flt3-related signal transduction pathways. This results in inhibition of tumor angiogenesis and tumor cell proliferation in PDGFR and/or Flt3 overexpressing tumor cells. PDGFR and Flt3, class III receptor tyrosine kinases, are upregulated or mutated in many tumor cell types.

Crenolanib Besylate Manufacturers

A Crenolanib Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crenolanib Besylate, including repackagers and relabelers. The FDA regulates Crenolanib Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crenolanib Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Crenolanib Besylate Suppliers

A Crenolanib Besylate supplier is an individual or a company that provides Crenolanib Besylate active pharmaceutical ingredient (API) or Crenolanib Besylate finished formulations upon request. The Crenolanib Besylate suppliers may include Crenolanib Besylate API manufacturers, exporters, distributors and traders.

Crenolanib Besylate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Crenolanib Besylate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Crenolanib Besylate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Crenolanib Besylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Crenolanib Besylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Crenolanib Besylate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Crenolanib Besylate suppliers with NDC on PharmaCompass.

Crenolanib Besylate Manufacturers | Traders | Suppliers

Crenolanib Besylate Manufacturers, Traders, Suppliers 1
30

We have 1 companies offering Crenolanib Besylate

Get in contact with the supplier of your choice:

  1. Dishman Carbogen Amcis
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY